by Washington University School of Medicine A new study from Washington University School of Medicine in St. Louis identifies a possible treatment strategy for some bone marrow failure syndromes. Shown are human embryonic stem cells engineered to have a mutation that causes poikiloderma with neutropenia, a bone marrow failure syndrome that increases a patient’s risk...
by Cedars-Sinai Medical Center Axial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domain Research led by investigators at Cedars-Sinai Cancer and Johns Hopkins University have discovered a novel three-step treatment that disrupts the pancreatic tumor microenvironment in laboratory mice. The preclinical study, published in the journal Gastroenterology, focuses on a trio...
QUEEN MARY UNIVERSITY OF LONDON An international collaboration involving researchers from Queen Mary University of London, Memorial Sloan Kettering Cancer Center (MSK), New York, and Dana-Farber Cancer Institute, Boston has secured a €1M research grant from Dutch blood cancer charity, Lymph&Co, to investigate a new treatment target for lymphoma. The aim of the project is...
by Albert Einstein College of Medicine Microscopic image of an HIV-infected T cell. Credit: NIAID Armed with a novel strategy they developed for bolstering the body’s immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice—offering a path to a functional cure for HIV and other chronic viral infections. Their...
by University of Texas M. D. Anderson Cancer Center A hairpin loop from a pre-mRNA. Highlighted are the nucleobases (green) and the ribose-phosphate backbone (blue). Note that this is a single strand of RNA that folds back upon itself. Credit: Vossman/ Wikipedia Researchers at The University of Texas MD Anderson Cancer Center have discovered a critical new...
